US 12,214,210 B2
Minimally invasive leadless neurostimulation device
Steven T. Deininger, Plymouth, MN (US); Jerel K. Mueller, Saint Paul, MN (US); Todd V. Smith, Shoreview, MN (US); Jeffrey Clayton, Zimmerman, MN (US); Thomas M. Hillebrand, Minneapolis, MN (US); Phillip C. Falkner, Minneapolis, MN (US); Jenna N. George, Edina, MN (US); and Sarah J. Offutt, Golden Valley, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Sep. 24, 2021, as Appl. No. 17/485,303.
Claims priority of provisional application 63/199,274, filed on Dec. 17, 2020.
Claims priority of provisional application 63/198,054, filed on Sep. 25, 2020.
Prior Publication US 2022/0096846 A1, Mar. 31, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/375 (2006.01); A61N 1/05 (2006.01)
CPC A61N 1/3756 (2013.01) [A61N 1/0551 (2013.01)] 23 Claims
OG exemplary drawing
 
1. A leadless neurostimulation device comprising:
a header unit comprising:
at least one primary electrode having a contact surface that defines an external surface of the leadless neurostimulation device, the at least one primary electrode comprising a cathode;
a housing comprising a secondary electrode positioned on the same side of the leadless neurostimulation device as the at least one primary electrode, the secondary electrode comprising an anode; and
processing circuitry within the housing configured to deliver electrical stimulation therapy, the processing circuitry electrically coupled to the at least one primary electrode and secondary electrode and are configured to transmit an electrical stimulation signal between the cathode in the header unit and the anode on the housing to provide the electrical stimulation therapy to a target nerve of a patient.